Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens.
Cotugno N, Franzese E, Angelino G, Amodio D, Romeo EF, Rea F, Faraci S, Tambucci R, Profeti E, Manno EC, Santilli V, Rotulo GA, Pighi C, Medri C, Morrocchi E, Colagrossi L, Pascucci GR, Valentini D, Villani A, Rossi P, De Angelis P, Palma P.
Cotugno N, et al. Among authors: rea f.
Vaccines (Basel). 2022 Jul 11;10(7):1109. doi: 10.3390/vaccines10071109.
Vaccines (Basel). 2022.
PMID: 35891273
Free PMC article.